Phio Pharmaceuticals Corp. (PHIO) — Institutional Holders, Q2 2026
24 institutional investment managers reported a PHIO position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $662.6K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
PHIO in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- NOMURA ASSET MANAGEMENT INTERNATIONALNew · +50,000 sh+$51.3K
- CITADEL ADVISORSNew · +47,150 sh+$48.3K
- VANGUARD CAPITAL MANAGEMENTAdded · +14,409 sh+$14.8K
- BRIDGEWAY CAPITAL MANAGEMENTNew · +12,000 sh+$12.3K
- CITIGROUPAdded · +10,580 sh+$10.8K
Biggest sellers
- GEODE CAPITAL MANAGEMENTTrimmed · -32,680 sh-$33.5K
- Scientech ResearchSold out · -30,032 sh-$30.8K
- UBS Group AGTrimmed · -21,600 sh-$22.1K
- HRT FINANCIALTrimmed · -21,550 sh-$22.1K
- GSA CAPITAL PARTNERS LLPSold out · -19,864 sh-$20.4K
PHIO 13F holders ranked 1–24 of 24
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | JANE STREET GROUP#1 · 117,755 sh | 117,755 | $120.7K | 0.00% | -1.2% |
| 2 | GEODE CAPITAL MANAGEMENT#2 · 114,574 sh | 114,574 | $117.4K | 0.00% | -22.2% |
| 3 | VANGUARD CAPITAL MANAGEMENT#3 · 94,262 sh | 94,262 | $96.6K | 0.00% | +18.0% |
| 4 | NOMURA ASSET MANAGEMENT INTERNATIONAL#4 · 50,000 sh | 50,000 | $51.0K | <0.01% | New |
| 5 | Cetera Investment Advisers#5 · 47,500 sh | 47,500 | $48.7K | 0.00% | +5.6% |
| 6 | CITADEL ADVISORS#6 · 47,150 sh | 47,150 | $48.3K | 0.00% | New |
| 7 | VANGUARD FIDUCIARY#7 · 38,169 sh | 38,169 | $39.1K | 0.00% | 0.0% |
| 8 | NORTHERN#8 · 27,768 sh | 27,768 | $28.5K | 0.00% | +16.9% |
| 9 | TWO SIGMA INVESTMENTS#9 · 21,501 sh | 21,501 | $22.0K | 0.00% | -33.8% |
| 10 | XTX Topco Ltd#10 · 18,475 sh | 18,475 | $18.9K | <0.01% | -25.7% |
| 11 | HRT FINANCIAL#11 · 13,182 sh | 13,182 | $13.0K | 0.00% | -62.0% |
| 12 | BRIDGEWAY CAPITAL MANAGEMENT#12 · 12,000 sh | 12,000 | $12.3K | <0.01% | New |
| 13 | CITIGROUP#13 · 11,605 sh | 11,605 | $11.9K | 0.00% | +1032.2% |
| 14 | CAPTRUST FINANCIAL ADVISORS#14 · 10,000 sh | 10,000 | $10.3K | 0.00% | 0.0% |
| 15 | Tower Research Capital (TRC)#15 · 6,206 sh | 6,206 | $6.4K | <0.01% | -18.6% |
| 16 | MORGAN STANLEY#16 · 6,000 sh | 6,000 | $6.2K | 0.00% | 0.0% |
| 17 | UBS Group AG#17 · 5,387 sh | 5,387 | $5.5K | 0.00% | -80.0% |
| 18 | OSAIC#18 · 2,000 sh | 2,000 | $2.1K | 0.00% | 0.0% |
| 19 | Spire Wealth Management#19 · 1,990 sh | 1,990 | $2.0K | <0.01% | -0.5% |
| 20 | SBI Securities , Ltd.#20 · 1,247 sh | 1,247 | $1.3K | — | +1.9% |
| 21 | BARCLAYS PLC#21 · 231 sh | 231 | $237.00 | 0.00% | New |
| 22 | ASSETMARK#22 · 110 sh | 110 | $113.00 | — | 0.0% |
| 23 | Activest Wealth Management#23 · 9 sh | 9 | $9.00 | — | 0.0% |
| 24 | Caitong International Asset Management , Ltd#24 · 6 sh | 6 | $6.00 | 0.00% | +100.0% |
Funds that sold out of PHIO in Q2 2026 (4)
Held PHIO at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Scientech Research30,032 sh | 30,032 | $36.6K |
| GSA CAPITAL PARTNERS LLP19,864 sh | 19,864 | $24.0K |
| TWO SIGMA SECURITIES15,224 sh | 15,224 | $18.6K |
| NBC SECURITIES1,074 sh | 1,074 | $1.3K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.